The number of people with susceptibility test result for rifampicin in Republic of Moldova
Republic of Moldova: The number of people with susceptibility test result for rifampicin was 96.4 in 2021. ▬ Flat
Latest (2021)
96.4
Change on year
up 1.1%
World rank
44th
of 146 countries
All-time high
96.65
in 2017
All-time low
95.35
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Republic of Moldova, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Republic of Moldova recorded 96.4 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of up 1.1% on the previous year and down 0.3% over five years.
That places Republic of Moldova 44th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Republic of Moldova, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 96.65 | — |
| 2018 | 96.61 | -0.0% |
| 2019 | 96.34 | -0.3% |
| 2020 | 95.35 | -1.0% |
| 2021 | 96.4 | +1.1% |
Republic of Moldova compared with similar countries
- Republic of Moldova's 96.4 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Republic of Moldova's 96.4 is above the median for Europe & Central Asia, which is 93.52, 1.0× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 96.53 | 96.34 | 96.65 | 3 |
| 2020s | 95.87 | 95.35 | 96.4 | 2 |
Countries ranked near Republic of Moldova
More health data for Republic of Moldova
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2486 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,492 deaths per 1,000 people (2090)
- Number of infants who die before age 1 29 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.71 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.026 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.57 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Republic of Moldova?
- The number of people with susceptibility test result for rifampicin in Republic of Moldova was 96.4 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Republic of Moldova?
- The highest recorded value was 96.65 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Republic of Moldova?
- The lowest recorded value was 95.35 in 2020.
- How does Republic of Moldova rank for the number of people with susceptibility test result for rifampicin?
- Republic of Moldova ranks 44th out of 146 countries with data for 2021.
- Where does this Republic of Moldova data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).